Joe Martinez
Center Point Clinical Services, USA
Title: Retrospective analysis of clinical pharmacist medication counseling to improve patient medication compliance and patient retention
Biography
Biography: Joe Martinez
Abstract
Poor patient retention and medication compliance represent an ongoing challenge in clinical trials. Patients have many instructions to follow and can become frustrated easily. In fact, according to research by the Tufts Center for the Study of Drug Development, 49% of all patients randomized into a clinical trial quit before study completion. Clinical trials provide important and critical medical and clinical data that are required for FDA review and approval of a drug, device or procedure application. Addressing the patient’s need for medication information can increase protocol compliance; while increased patient retention and can have a beneficial impact on achieving primary endpoints and health outcomes. Statistical analysis of multiple clinical trials involving a chronic disease medication (diabetes) with clinical pharmacist medication counseling resulted in total of 21,582 CTRP (Pharmacist) calls were made to 3,124 clinical trial patients, 92.8% (2,900) of patients had at least one intervention, 45.7% (9,845) of clinical patient calls had at least one intervention and most frequent interventions were for concurrent medications (31.7%), miscellaneous concerns (24.9%), side effects (19.0%) and IVRS (19.0%). Clinical pharmacist medication counseling support was observed as a motivating factor for the patient to comply with study protocol directions and provided enhance patient retention. Increasing patient retention can save an average of $36,500 per patient and potentially shorten the study duration. Patient compliance increased by more than 25% percent and patient retention rates improved by 60 percent in these clinical trials, with results ranging up to 93 percent retention when compared to anticipated outcomes.